The top news stories from Asia and the Pacific

Provided by AGP

The Asia Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Asia Gazette.

Press releases published on May 4, 2026

Kyverna Therapeutics Appoints Nadia Dac, Seasoned Commercial Leader in Neurology and Rare Disease, as Chief Commercial Officer
Atsena Presents Positive Interim Six-Month Results from Part B of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis
After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS
Ruanyun Edai Technology’s Saudi RHQ Signs MOU with Wadi Makkah, A Subsidiary of Umm Al-Qura University
Mint Incorporation Limited Announces 1-for-10 Reverse Stock Split
Propella Group and TISTR Sign MOU to Fast-Track Commercialization of Thailand's Deep Tech IP
Panoro Announces Brokered LIFE Offering for Gross Proceeds of up to $20 Million
MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement
BridgeBio to Present New Acoramidis Data on Disease Progression, Biomarkers, and Clinical Outcomes at ESC-Heart Failure 2026
Dynacor Group Receives TSX Approval To Renew Normal Course Issuer Bid
Groupe Dynacor : TSX approuve la poursuite de l’offre publique de rachat d’actions dans le cours normal des activités
DEEP SEA MINERALS CORP. PARTICIPATES IN EXIM BANK’S 2026 ANNUAL CONFERENCE IN WASHINGTON, DC
InflaRx Reports Favorable Reactive Metabolite Profile for Izicopan in Human Liver Microsomes
Discovery Announces Details of First Quarter 2026 Results Conference Call and Webcast
Windward Bio Announces $165M Crossover Financing to Advance Pipeline of Long-Acting Immunology Therapies With Best-in-Disease Potential
Forte Minerals Graduates to OTCQX® Best Market
Indivior Announces $175 Million Accelerated Share Repurchase
BioCryst Announces European Licensing Agreement with Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema
GFG Significantly Expands Goldarm Property Following Encouraging Regional Exploration Results in the Timmins Gold District
Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering

Share us

on your social networks:

Sign up for:

The Asia Gazette

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.